Aclinical research scientist, professor,and Founder CEO of Academically Global
Express Healthcare®
POSTEVENTS
22 AOCR 2025 SUCCESSFULLY CONCLUDES IN CHENNAI
23 INDIATRIUMPHS IN INTERNATIONAL RADIOLOGYQUIZ ATAOCR 2025
24 BPLMEDICAL TECHNOLOGIES SHINES ATAOCR 2025
26 SHAPING LEADERSHIPFOR DYNAMIC INDIAN HEALTHCARE LANDSCAPE LEADERSHIP
28 UNLEASHING INDIA'S MEDTECH POTENTIAL: PAVING THE PATH TO AVIKSIT BHARAT MEDTECH
29 ADVANCING CANCER CARE WITH PRECISION: THE EDGE RADIOSURGERYSYSTEM RADIOLOGY
Regd.With RNI No.MAHENG/2007/22045.Postal Regd.No.MCS/162/2025 - 27.Printed and Published byVaidehi Thakar on behalf of The Indian Express (P) Limited and Printed at The Indian Express Press,Plot No.EL-208,TTC Industrial Area,Mahape,Navi Mumbai-400710 and Published at Mafatlal Centre,7th floor,Ramnath Goenka Marg,Nariman Point,Mumbai 400021.
Reproduction in anymanner,electronic or otherwise,in whole or in part,without prior written permission is prohibited.
Budget blues hit the healthcare sector
On the face of it, the Union Budget 2025-26 has many positives for the healthcare sector. But a careful examination suggests that it could turn out to be a sugar coated bitter pill.
Allocation for healthcare has increased by around 10.8 per cent, from the revised budget Rs 86,582.48 crore in FY2024-25 to Rs 95,957.87 crore in FY2025-26. The Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (PM-JAY) received a 28.8 per cent increase in allocation, rising from Rs 7,299 crore last year to Rs 9,406 crore in FY2026.
Union Finance Minister Nirmala Sitharaman’s announcement that almost 1.1 lakh UG and PG medical education seats would be added in 10 years, with 10,000 additional seats being added over the next year in medical colleges and hospitals, is also a positive. The aspirational target is to add 75,000 seats in the next five years. Hopefully this will take us closer to bridge India's doctor-patient ratio of 1:834 to the World Health Organization’s (WHO) recommended 1:1000.
However, the increase in the number of medical seats is meaningless without the infrastructure and teachers to teach these 10,000 extra medical students, raising doubts on the quality of medical education. Questions are also being raised on the lack of infrastructure and incentives to prevent medical graduates from migrating abroad for better job prospects.
The real task is incentivising medicos to practise where India needs doctors, like the rural areas etc.
Another headline grabbing announcement was the establishment of daycare cancer centers in all district hospitals within the next three years, with a target to add 200 in the first year itself.
It's a good move to decentralise cancer care, taking it to the grassroot level. One could also argue that these centres will be able to absorb the 10,000 extra medical students.
However, most medical students would prefer not to be based in district towns. Secondly, private sector cancer care companies have pointed out that cancer care is more complex and quality of care could suffer at these daycare centres, as oncologists and specialised onco paramedical staff would also need to be based at such centres.
However, diagnostics players have posited that these daycare cancer centres could focus on early diagnosis and screening initiatives and supportive care between chemo cycles. Read together with the push to provide broadband services and improve digital infrastructure at primary healthcare centres, this
After the euphoria of budget day,the private sector finds that there are no specific policy measures to incentivise their contributions to the larger public good
could potentially improve telemedicine services and attract diagnostics providers to expand their services to the hinterland.
Diagnostics companies have mostly seen the budget as positive for them, but point out that GST rationalisation and increasing tax exemption for preventive health check-ups would result in a win-win proposition: encourage regular testing, leading to early diagnosis and better treatment outcomes for patients. For diagnostics players, this would mean stronger revenues.
Another win-win proposal is the proposal for basic custom duty exemption on 36 life-saving drugs, 5 per cent customs duty reduction on six others, and the addition of 13 new patient assistance programmes that will reduce the burden on patients’ pockets. It will also help more patients take the full treatment regimen, rather than drop off due to financial reasons. As the full exemption and concessional duty will also apply to the bulk drugs required for making these drugs, this will incentivise pharma companies to focus on these therapies, as increased access translates to larger revenues in the long run. The budget pushes for the Heal in India initiative, encouraging medical tourism which could incentivise private healthcare providers to increase capacity and create more employment opportunities in the healthcare sector.
However, the indigenous medical devices and technology manufacturers feel left out of this budget, as there was little to no support for them in the form of increased customs duty on imported devices or rationalising GST rates. Diagnostics and imaging equipment makers and users would have also benefited from lower and simpler GST rates.
Thus while the Union Budget 2025-26 seems like a bonanza for the healthcare sector, closer scrutiny reveals many gaps. A lot hinges on the implementation of these proposals in a timely manner, with optimum utilisation of allocated funds.
After the euphoria of budget day, the private sector finds that there are no specific policy measures to incentivise their contributions to the larger public good via public-private- partnerships. Will it be back to a stalemate between government, policy makers and the private healthcare representatives once again?
Diagnostic companies can bridge healthcare gaps in underserved areas
Dr Anand K, MD & CEO,Agilus Diagnostics in an interaction with Kalyani Sharma talks about the current state,challenges and future of diagnostics in India
How do you perceive the current state of the diagnostics industry, and what key trends are shaping its evolution?
The Indian diagnostics industry, valued at ~$13 billion in FY23, has become a key player in the healthcare sector, offering attractive margins and immense growth potential. Projected to grow at a CAGR of ~14 per cent over the next five years, this expansion is driven by factors such as the rising prevalence of chronic diseases, an aging population, increasing demand for preventive tests, and supportive government initiatives.
The diagnostics industry is in a period of profound transformation. It is no longer limited to disease detection but is now a cornerstone of preventive and personalised healthcare. The growing awareness among consumers about early detection and wellness is a key driver, pushing the industry towards innovation. Key trends include the rapid adoption of Artificial Intelligence (AI) to improve diagnostic accuracy and reduce turnaround times. Digital pathology is reshaping the way pathologists work, enabling remote consultations and second opinions.
The modern diagnostics industry in India has successfully made high-end tests both accessible and economical for the population
While the Indian diagnostics industry has witnessed rapid evolution and robust growth, its regulatory framework remains underdeveloped. Unlike many global counterparts, India lacks mandatory minimum standards for operating diagnostic laboratories, leaving the sector largely unregulated. Accreditation from bodies such as NABL (National Accreditation Board for Testing and Calibration Laboratories) is entirely voluntary, leading to significant variability in the quality and reliability of diagnostic services. This regulatory gap creates challenges in ensuring uniformity in testing practices, equipment standards, and personnel qualifications, which can impact the accuracy of diagnostics—a critical component of healthcare. Without mandatory oversight, smaller or unaccredited labs may operate without adhering
to best practices, potentially jeopardising patient safety and trust. Addressing this issue through comprehensive regulations and mandatory accreditation could significantly enhance the quality and credibility of diagnostic services in India.
How can diagnostics companies contribute to strengthening healthcare infrastructure in underserved regions, particularly tier 2 and 3 cities?
According to the Healthcare
Federation of India, over 50 per cent of aspirational districts identified by NITI Aayog—regions characterised by limited access to essential infrastructure—are served by diagnostic chains. This highlights the growing significance of diagnostics in the healthcare continuum and underscores the deepening reach of diagnostic providers into India's hinterlands.
Diagnostics companies can bridge healthcare gaps in underserved areas by making diagnostics more accessible and affordable. Establishing satellite labs and collection centers in tier 2 and 3 cities can reduce the time and cost burden on patients.
Leveraging telemedicine and digital platforms enables expert consultations even in remote locations.
Partnerships with local governments and healthcare organisations can facilitate health camps and awareness drives.
What challenges do you foresee for the diagnostics sector in the next five years, and how is Agilus preparing to address them?
The modern diagnostics industry in India has successfully made high-end tests both accessible and economical for the population. Operating at some of the lowest price points globally, the industry exemplifies a unique balance between affordability and innovation.
For instance, the uninsured cost of lab tests in countries like the USA and New Zealand is approximately eight times and two times higher than in India, respectively. Even when compared to underdeveloped nations, Indian diagnostics
remain significantly more affordable—test prices in Kenya are nearly four times higher, while those in Rwanda are two-and-a-half times higher than in India.
This cost-effectiveness is achieved without compromising on quality, as the industry continues to innovate its delivery models and prioritise patient-centric solutions. Through initiatives such as home sample collections, digital reporting, and preventive health packages, Indian diagnostic players have redefined healthcare accessibility, ensuring that affordability does not come at the cost of convenience or patient care.
Regulatory gaps, a shortage of skilled professionals in advanced diagnostic fields, and high customs duties on imported diagnostic equipment and kits continue to hinder its progress.
Establishing mandatory governance standards could address regulatory concerns, ensuring uniformity and quality across laboratories. Additionally, reducing customs duties on diagnostic imports would lower operational costs, enabling providers to offer advanced tests at more affordable rates.
To tackle the talent shortage, creating an allied body dedicated to certifying and accrediting lab professionals could elevate the profession’s stature and attract more talent to the field. By promoting laboratory technologists as a critical and rewarding career path, the industry can nurture a skilled workforce, laying the foundation for sustainable growth and innovation in
diagnostics. By focusing on patientcentric innovations, stringent quality controls, and workforce development, Agilus Diagnostics is not only addressing industry challenges but also setting new standards for excellence in diagnostics.
How are emerging technologies like AI, machine learning, and big data analytics transforming diagnostics?
Emerging technologies are a game-changer in diagnostics. AI and ML are enhancing diagnostic precision, especially in areas like radiology and pathology, by identifying patterns and anomalies that may elude the human eye. These technologies also optimise laboratory workflows, reducing turnaround times significantly. Big data analytics is enabling a shift from reactive to predictive healthcare, analysing trends and identifying population health risks early. For example, genomics benefits greatly from AI, as algorithms can sift through vast datasets to identify genetic mutations and provide actionable insights. At Agilus Diagnostics, our digital pathology division uses AI for cancer diagnosis, allowing multiple pathologists to collaborate seamlessly, ensuring accurate and timely results.
With the rise of point-ofcare testing and at-home diagnostics, how do you see the role of traditional labs evolving?
Traditional labs are evolving to complement point-of-care testing and at-home diagnostics rather than compete with them. While rapid testing fulfils the need for convenience, traditional labs will continue to be indispensable for specialised testing, advanced diagnostics, and confirmatory tests. They are becoming hubs for innovation, focusing on cutting-edge research and diagnostics, such as genomic sequencing and digital pathology. Traditional labs
also play a vital role in data interpretation and integration, ensuring the accuracy and reliability of test results. Agilus Diagnostics is
adapting to this shift by integrating digital platforms to offer a hybrid model that blends home collection services with comprehensive
lab testing.
What regulatory changes would you like to see to support the growth and
innovation in the diagnostics industry?
To foster growth and innovation, we need regulatory reforms that strike a balance
DIAGNOSTICS
between ensuring patient safety and encouraging innovation. A unified regulatory framework across states in India would reduce complexity and increase efficiency. Incentivising research and development through grants and tax benefits can boost innovation in advanced diagnostics. Regulatory support for adopting emerging technologies, such as AI and telepathology, would enable faster implementation and wider acceptance. Agilus Diagnostics advocates for a collaborative approach between industry stakeholders and regulators to create policies that enhance patient care while promoting industry growth.
One of the most important
challenges today facing the diagnostic industry is the lack of qualified pathologists in proportion to the increasing population and growing complexity of diseases. It is also important to note that it takes over ten years or more to become a well-qualified pathologist in India. In fact, shortage of pathologists is a global concern. As per estimates by the World Health Organisation, there were an estimated 13.2 medical doctors worldwide. Pathologists account for about 0.5-1 per cent of all clinicians. A growing number of studies from many countries indicate a shortage of pathologists, an increase in workload, and a potential workforce crisis in the near future, which could all negatively impact patient care.
Medical technologists are crucial to the Indian Diagnostic Industry, wielding expertise in clinical laboratory testing and are primarily responsible for ensuring the accuracy of laboratory processes and results. Their role is central to disease detection, management, and public health surveillance, contributing to early diagnosis and effective treatment. It is important to recognise this crucial work and cultivate the next generation of laboratory professionals while prioritising patient safety and care.
Can you share insights into your organisation's plans for expansion, particularly in tier 2 and tier 3 cities? Are there specific partnerships or collaborations in the
pipeline?
As the largest diagnostic chain in India, Agilus Diagnostics has established a robust presence in 25 states and 5 union territories, spanning 550 districts. Our network includes 410+ laboratories, 3,900+ customer touchpoints, and 14,000+ direct clients across 1,000+ cities, with a strong emphasis on tier 2 and tier 3 markets. This expansive reach allows us to deliver reports to patients in the shortest possible time, ensuring accessibility and efficiency.
Internationally, our footprint extends across the SAARC region, Sub-Saharan Africa, Southeast Asia, CIS, Gulf, and the Middle East, with over 1,000 customer touchpoints, including more
than 120 collection centers and 800 direct clients. While geographical expansion remains a priority, we are equally focused on diversifying our test menu to include cutting-edge diagnostics. Special attention is being given to genomics and companion diagnostics, recognising their transformative potential in personalised care and precision medicine. By investing in advanced diagnostic capabilities and forging strategic partnerships, we aim to stay at the forefront of healthcare innovation, catering to the evolving needs of patients and healthcare providers alike.
AcademicallyGlobal provides comprehensive guidance and training to healthcare professionals
Dr Akram Ahmad, a clinical research scientist,professor,and Founder CEO of Academically Global in an interaction with ExpressHealthcare shares his journey,vision and the vital role his organisation plays in supporting healthcare professionals pursuing international opportunities
What inspired you to establish this organisation?
What gaps did you identify in training and migration support for healthcare professionals?
During my PhD from the faculty of medicine and health, the University of Sydney, Australia, I encountered many students from India— pharmacists, medical doctors—working odd jobs like driving taxis or working in small stores. They came on study visas through agents who prioritised commissions over students' futures. Many of these students had taken loans or sold land to fund their education but lacked proper guidance to secure jobs in their field.
This realisation began during a conversation with an Uber driver, a qualified pharmacist in India who was unaware of the licensing exam required in Australia. I guided him, and he eventually became a practicing pharmacist. These experiences motivated me to start helping healthcare professionals navigate the complex migration process.
How did you transition from helping individuals to starting an organisation?
It began in 2018 when I made a video explaining the process of becoming a licensed healthcare professional in Australia. The response was overwhelming, and people began reaching out for guidance. While continuing my government job in Australia, I dedicated time to making videos and answering queries.
Eventually, with my wife’s support, I decided to establish a platform to provide structured support. Initially, I managed
everything—marketing, sales, video creation—but as demand grew, I focused entirely on the organisation, leaving my government job – and that’s how Academically was born.
What kind of services does your organisation offer to healthcare professionals Academically Global provides comprehensive guidance and training to healthcare professionals, including pharmacists, doctors, and nurses, helping them navigate the complex process of securing licensure and employment in countries like Australia, New Zealand, the UK, the Gulf, Ireland, and Canada. We specialize in preparing candidates for critical licensing exams such as the OPRA exam for pharmacists, AMC for doctors, and other country-specific assessments for various healthcare verticals. Our
services go beyond exam preparation—we offer end-toend support, including assistance with visa applications, interview preparation, and job placement assistance, ensuring our clients not only pass exams but also secure permanent positions and pathways to residency.
Which countries are the most challenging for healthcare professionals to migrate to, and how does your organisation help?
Countries like Australia, New Zealand and Ireland have rigorous licensing exams, but we provide comprehensive training to bridge these gaps. One advantage is that some exams can now be taken from their home country, reducing financial and logistical barriers. We make sure to be very transparent and only provide training for licensing exams for countries where there is both a
demand as well as a streamlined pathway for migration.
What challenges do healthcare professionals face when pursuing international careers, and how does your organisation address them?
The major challenges include a lack of awareness about licensing requirements, insufficient practical knowledge, and language barriers. We address these through targeted training programs, mock tests using adaptive AI, and courses to improve communication skills, especially for students from non-English medium backgrounds.
How do you see technology, like AI, transforming healthcare education?
AI is a game-changer. We use adaptive AI for mock tests, offering personalised feedback and enhancing learning efficiency. AI can also simplify complex topics, such as cardiovascular and nervous systems, making them easier to grasp for students.
Do you notice a significant number of students from tier 2 and 3 cities seeking your services?
Yes, a majority of our students come from tier 2 and 3 cities, including UP, Bihar, and Haryana. Many are Hindimedium students who excel academically but struggle with English proficiency. We help them clear not only their pharmacy and medical exams but also language tests. Communication is a critical skill often overlooked in Indian healthcare education. Many students from government or
non-English medium schools struggle to express their knowledge, which becomes a barrier when working abroad. We focus on improving their language and interpersonal skills to prepare them for global opportunities.
What are your future plans for the organisation?
We aim to expand our services to more countries, particularly in Europe, where healthcare professionals are in high demand. Our goal is to bridge the gap between unemployment in India and some countries and the global need for skilled healthcare professionals. Over the next five years, we plan to launch new courses for upskilling and collaborate with more international institutions.
Any advice for young professionals aspiring to build international careers. Internships are gamechangers for young professionals aiming for international careers. Based on my experience in Malaysia and Australia, internships at every stage provide critical skills, real-world exposure, and a deeper understanding of your field. In India, this hands-on experience is often overlooked, but it can set you apart. Alongside internships, engaging in research projects and publishing papers strengthens your academic profile and boosts your chances for scholarships and higher studies. With the right guidance and early exam preparation, students can unlock vast opportunities globally. Practical experience, not just academic excellence, is the key to success.
Despite challenges,diagnostics in tier 2 and 3 cities are growing through PPPs and technology adoption
By Kalyani Sharma
India’s tier 2 and tier 3 cities have historically faced significant challenges in healthcare, particularly in diagnostics. Limited infrastructure, a shortage of trained professionals, and low awareness about preventive healthcare have resulted in delayed diagnoses and inadequate treatment. However, a paradigm shift is underway, driven by advancements in technology, government initiatives, and increased private sector investments. While substantial progress has been made, challenges persist, necessitating a multi-pronged approach to ensure equitable access to quality diagnostic services.
Dr Aakaar Kapoor, CEO and Lead Medical Advisor, City X-Ray and Scan Clinic; Founder and Partner, City Imaging & Clinical Labs says, “Tier 2 and 3 cities play a crucial role in shaping the future of healthcare in India. These regions serve 67 per cent of the population, yet face significant challenges in healthcare accessibility, with a doctor-topatient ratio of 1:25,000. Demand for diagnostic testing is witnessing rapid increase in smaller towns, prompting organised diagnostic services firms to focus on expanding into these areas.”
“Tier-2, tier-3, and smaller towns are increasing at a 25 per cent compounded annual growth rate (CAGR), whereas metros are growing at 10 per cent (due to their large base). According to preliminary estimates, tier-2 and 3 towns provide for around 40 per cent of total diagnostic sector income, with the remainder coming from the top cities. While metro markets are increasing at 10 per cent, smaller communities are growing at around 25 per cent. Within 2-3 years, the revenue ratio between major cities and small villages is predicted to reach 50/50.
The diagnostics sector in India is presently valued at $14-15 billion and increasing at a rate of 13-14 percent per
There is a rising recognition of the need for digital solutions,resulting in the steady use of electronic health records (EHRs),telemedicine platforms,and mobile health applications
Dr Aakaar Kapoor
CEO
and Lead Medical Advisor, City X-Ray and Scan Clinic; Founder and Partner, City Imaging & Clinical Labs
The diagnostics industry in India's smaller cities is changing a lot. These changes show a shift in healthcare priorities,with more focus on using technology and preventing diseases
Dr Maithili Kavathekar Director-Lab Services, Sahyadri Hospitals, Sahyadri Speciality Labs
Government initiatives and private sector investments are gradually enhancing the availability and quality of diagnostic services,aiming to bridge the existing gaps and ensure equitable healthcare access across the country
Surendran Chemmenkotil CEO, Metropolis Healthcare
Another interesting trend is in the growth of point-of-care testing as we have learnt to miniaturise and make portable the instrumentation required to take testing into the remote field sites and at the point of need
Professor Vijay Chandru
Co-Founder and Director,Strand Life Sciences
and CRISPRBITS
year. The organised sector accounts for about 25 per cent of this segment (15 per cent in laboratories and 10 per cent in radiology).”
Dr Maithili Kavathekar, Director-Lab Services, Sahyadri Hospitals, Sahyadri Speciality Labs also mentions, “The diagnostics industry in India's smaller cities is changing a lot. These changes show a shift in healthcare priorities, with more focus on using technology and prev enting diseases. Smaller cities are starting to have better healthcare services, which are becoming more like those in bigger cities.”
Current state of diagnostics infrastructure in tier 2 and tier 3
The diagnostic ecosystem in smaller cities has traditionally been fragmented, with a heavy reliance on primary healthcare centers and local pathology labs with limited capabilities. Many tier 2 and tier 3 cities lack advanced diagnostic equipment such as MRI and CT scanners, often requiring patients to travel to metros for critical tests.
Surendran Chemmenkotil, CEO, Metropolis Healthcare stresses, “India's diagnostics industry is valued at approximately US$13 billion in FY23, however it is largely fragmented, with a significant presence of standalone centers and private hospitalbased labs, while national chains hold a smaller share of the market. In tier 2 and tier 3 cities, this fragmentation leads to challenges such as inconsistent quality standards and limited access to advanced diagnostic services. The uneven distribution of healthcare facilities further exacerbates disparities in diagnostic accessibility. However, the rising prevalence of chronic diseases and an increasing demand for preventive tests are driving the need for improved diagnostic infrastructure in these regions. Government initiatives and private sector investments
are gradually enhancing the availability and quality of diagnostic services, aiming to bridge the existing gaps and ensure equitable healthcare access across the country.”
While many diagnostic chains are expanding their footprints, the penetration remains insufficient to cater to the growing population’s needs. Furthermore, the cost of setting up advanced diagnostic centers remains a major deterrent, leading to gaps in service availability.
According to Professor Vijay Chandru, Co-Founder and Director, Strand Life Sciences and CrisprBits, “Diagnostics infrastructure in tier 2 and tier 3 cities is often outdated, with many regions relying on older generation equipment and limited facilities. For example, molecular diagnostic tests, essential for identifying genetic disorders or identifying the right therapies for cancers, are still unavailable or unaffordable in several small towns. This lack of access leads to delays in diagnosis and treatment, disproportionately affecting health outcomes in these regions.”
Technologyadoption to bridge geographical barriers
To bridge geographical barriers, technology-driven solutions like tele-diagnostics are gaining momentum. The integration of artificial intelligence (AI) and digital pathology has enabled remote analysis of samples, reducing turnaround time and improving diagnostic accuracy.
The health IT ecosystem in India's tier 2 and tier 3 cities is growing yet still fragmented. While metropolitan areas have advanced healthcare systems that include digital solutions, smaller cities frequently lack basic IT infrastructure.
Dr Kapoor stressses, “Many healthcare practitioners continue to use manual record-keeping methods and confront data management issues. However, there is a
Advancements in diagnostic technology,such as handheld X-ray devices and mobile imaging solutions, are playing a crucial role in bridging geographical barriers
Chander Shekhar Sibal
Vice
President-Medical Systems Division, FUJIFILM
Connecting the reference laboratories with the small scale laboratories in rural & tier 2 cities could enhance the use of advanced tests
Dr Nanda Kachare Consultant - Pathology & Head of Department of pathology and Laboratory Medicine, Jupiter Hospital
rising recognition of the need for digital solutions, resulting in the steady use of electronic health records (EHRs), telemedicine platforms, and mobile health applications.”
Chander Shekhar Sibal, Vice President-Medical Systems Division, FUJIFILM India highlights that, “Advancements in diagnostic technology, such as handheld X-ray devices and mobile imaging solutions, are playing a crucial role in bridging geographical barriers. These innovations enable healthcare professionals to conduct on-the-spot diagnostics, facilitating early detection of critical diseases even in remote areas.”
PPPs can help bridge infrastructure gaps by combining government support with private sector innovation,leading to better equipment,mobile testing units, and digital diagnostics
Vikram Thaploo CEO-Telehealth, Apollo Hospitals
The application of private sector intervention in public health matters focuses on accelerating product development and market reach of needed diagnostics
Shiva Sriram
President, Business Development, Molbio Diagnostics
Dr Nanda Kachare, Consultant - Pathology & Head of Department of pathology and Laboratory Medicine, Jupiter Hospital suggest, “Connecting the reference laboratories with the small scale laboratories in rural & tier 2 cities could enhance the use of advanced tests like molecular, cytogenetic testing and NGS facilities for the patients in rural areas and small cities.”
Tele-radiology, where scans are interpreted remotely by expert radiologists, has significantly enhanced access to specialised care. Mobile diagnostic units equipped with portable devices are also playing a crucial role in reaching underserved areas, ensuring timely intervention for patients in need.
Explaining how tele-diagnostics is emerging as a gamechanger in bridging the healthcare divide between urban and rural areas, Dr Kavathekar shares, “This technology allows for remote consultation and diagnosis, thus overcoming the geographical and logistical barriers that often are challenging in accessing healthcare services in less developed areas. For instance, digital platforms can transmit radiological images and medical test results to specialists in urban centers for analysis and diagnosis. This not only speeds up the healthcare delivery process
but also ensures that patients in tier 2 and tier 3 cities receive expert opinions without the need for extensive travel.”
Professor Chandru also explains, “Another interesting trend is in the growth of point-of-care testing as we have learnt to miniaturise and make portable the instrumentation required to take testing into the remote field sites and at the point of need. Portable imaging platforms bolstered by AI, battery-operated PCRs and cutting edge point-of-care nucleic methods using isothermal amplification and even CRISPR guided detection systems are at various stages of rollout across the country and offer great promise for public health and bio security, two sides of the same coin.”
“Finally, technology and reagent indigenisation for cost optimisation needs to be a major focus if we want affordable diagnostics that can reach remote corners of the country. Affordability must become a driver of inn ovation in these efforts. Sometimes, these optimisation efforts are not recognised as worthy of a research focus and overlooked. Policies and funding mechanisms are needed to induce the smartest scientific and technological talent in the country to be trained on this objective.”
Role of Public-Private Partnerships (PPPs)
PPPs have emerged as a viable model to improve the accessibility and affordability of diagnostic services. Several state governments have collaborated with private diagnostic chains to establish high-quality labs in district hospitals, offering subsidised testing for economically weaker sections.
Emphasising on the importance of PPPs, Vikram Thaploo, CEO-Telehealth, Apollo Hospitals said, “The pandemic showcased the potential of PPPs in improving accessibility, as government agencies, healthcare providers, and
technology firms collaborated to deliver faster, more efficient diagnostic solutions. PPPs can help bridge infrastructure gaps by combining government support with private sector innovation, leading to better equipment, mobile testing units, and digital diagnostics. Additionally, PPP-led training programs can address the shortage of skilled professionals, ensuring high-quality services in smaller cities.”
The Ayushman Bharat
By investing in education and training, we can empower local communities and ensure that they have the necessary resources to operate and maintain advanced diagnostic facilities
Deepak Sharma Co-Founder & CEO, MedLern
Training programs in tier 2 and 3 cities will help lab technicians by helping them gain hands-on experience
Dr Rajesh Bendre
Chief Pathologist and National Technical Head, Global Reference Laboratory, Apollo Diagnostics
Government policies must focus on incentivising skilled professionals to work in tier 2 and 3 cities
Dr Ashwini Lekhi
Lab Director, RJN Apollo Spectra Hospital Gwalior
scheme has further facilitated access by integrating diagnostics into its health and wellness centers. Encouraging such collaborations can help accelerate the expansion of diagnostic services in smaller cities and towns.
Shiva Sriram, PresidentBusiness Development, Molbio Diagnostics shares, “The application of private sector intervention in public health matters focuses on accelerating product development and
market reach of needed diagnostics. Government initiatives, such as Ayushman Bharat and PPPs, are helping address accessibility challenges by funding diagnostic services and establishing mobile health units. Corporate social responsibility (CSR) efforts are also contributing to improving accessibility in underserved regions. Despite these measures, affordability remains a concern for economically weaker populations.
Continued collaboration between the government, private sector, and NGOs is essential to bridging the diagnostic gap and ensuring equitable healthcare for tier 2 and tier 3 cities.”
Building a skilled workforce
A major bottleneck in scaling diagnostics infrastructure in tier 2 and 3 cities is the shortage of skilled technicians and healthcare professionals. Addressing this issue requires targeted training programs to build a competent workforce. Several diagnostic chains and educational institutions have launched certification programs for lab technicians, radiologists, and pathology experts. Additionally, initiatives like online training modules and hands-on workshops can help upskill existing professionals, ensuring high-quality service delivery.
Chemmenkotil also opines that developing a skilled workforce is imperative for the effective delivery of diagnostic services in tier 2 and tier 3 cities.
He said, “Training programs focusing on laboratory technicians and other healthcare professionals are essential to enhance competencies in operating advanced diagnostic equipment and adhering to quality standards. Public-private partnerships can facilitate these initiatives by providing resources and expertise for comprehensive training modules. Additionally, integrating digital tools and e-learning platforms can make training more accessible, allowing for continuous professional development. Such efforts not only improve the quality of diagnostics but also contribute to employment opportunities and economic growth in these regions, fostering a more robust healthcare ecosystem.”
Deepak Sharma, CoFounder & CEO, MedLern stresses that while challenges remain, the commitment to enhancing healthcare access
through technology and workforce development represents a significant step forward in addressing the healthcare disparities faced by these regions.
“There is an urgent need for comprehensive training programs designed to create a skilled workforce of lab technicians and healthcare professionals in tier 2 and tier 3 cities. By investing in education and training, we can empower local communities and ensure that they have the necessary resources to operate and maintain advanced diagnostic facilities.
Sriram opines that professional development and refresher courses must be encouraged and made available to the medical staff and medical personnel. This filters down to the other areas as it improves medical care where it is greatly needed.
Dr Rajesh Bendre, Chief Pathologist and National Technical Head, Global Reference Laboratory, Apollo Diagnostics said, “Training programs in tier 2 and 3 cities will help lab technicians by helping them gain hands-on experience, certifications, and technology-driven learning for strengthening the diagnostic services in the country. This will allow for improved diagnostic accuracy and expand healthcare access, ensuring that even smaller cities have well-trained professionals to handle advanced medical testing detect any disease early, and start timely treatment.”
According to Dr Ashwini Lekhi, Lab Director, RJN Apollo Spectra Hospital Gwalior, “Despite the challenges, there are significant opportunities to create a skilled workforce in tier 2 and
CONTRIBUTOR’S CHECKLIST
● Express Healthcare accepts editorial material for the regular columns and from pre-approved contributors/ columnists.
● Express Healthcare has a strict non-tolerance policy towards plagiarism and will blacklist all authors found to have used/referred to previously published material in any form, without giving due credit in the industryaccepted format.
● As per our organisation’s guidelines,we need to keep on record a signed and dated declaration from the author that the article is authored by him/her/them,that it is his/her/their original work,and that all references have been quoted in full where necessary or due acknowledgement has been given.The declaration also needs to state that the article has not been published before and there exist no impediment to our publication.Without this declaration we cannot proceed.
● If the article/column is not an original piece of work,the author/s will bear the onus of taking permission for re-publishing in Express Healthcare.The final decision to carry such republished articles rests with the Editor.
● Express Healthcare’s prime audience is senior
3 cities. Government initiatives and private partnerships can play a crucial role in bridging the gap. Programs like the Skill India Mission and other healthcare-focused initiatives aim to provide vocational training to individuals in smaller cities.”
Challenges,opportunities,and the need of the hour
Despite the advancements, several challenges remain. High capital investment, lack of regulatory compliance in smaller diagnostic setups, and resistance to adopting new technologies hinder growth. Additionally, a lack of awareness about p reventive healthcare continues to be a barrier, as many individuals only seek diagnostic services after the onset of severe symptoms. However, the rising demand for affordable health-
care solutions, increasing insurance penetration, and government-led initiatives to strengthen the healthcare ecosystem create a favorable environment for growth. To capitalise on these opportunities, stakeholders must work collaboratively to improve infrastructure, enhance affordability, and drive awareness campaigns on the importance of early diagnostics.
Dr Lekhi also opines that government policies must focus on incentivising skilled professionals to work in tier 2 and 3 cities. Awareness campaigns are also crucial. Highlighting the importance of healthcare roles and showcasing success stories can inspire more young people to pursue careers in this field. Schools and colleges should include healthcare-related courses to introduce students to these opportunities early on. The time
management and professionals in the hospital industry.Editorial material addressing this audience would be given preference.
● The articles should cover technology and policy trends and business related discussions.
● Articles by columnists should talk about concepts or trends without being too company or product specific.
● Article length for regular columns: Between 1300 - 1500 words.These should be accompanied by diagrams,illustrations,tables and photographs,wherever relevant.
● We welcome information on new products and services introduced by your organisation for our Products sections.Related photographs and brochures must accompany the information.
● Besides the regular columns,each issue will have a special focus on a specific topic of relevance to the Indian market.You may write to the Editor for more details of the schedule.
● In e-mail communications,avoid large document attachments (above 1MB) as far as possible.
● Articles may be edited for brevity,style,
relevance.
to act is now. With collective efforts, we can build a robust healthcare system that meets the needs of every citizen, regardless of their location.
Wayforward
The transformation of diagnostics in tier 2 and 3 cities is a critical component of India’s broader healthcare evolution. Technology integration, partnerships, and workforce development are playing a pivotal role. Sustained efforts are needed to address the existing gaps. By pushing innova tion, improving accessibility, and prioritising affordability, India can ensure that quality diagnostics reach beyond metros, ultimately leading to better health outcomes and a stronger healthcare ecosystem.
● Do specify name,designation,company name, department and e-mail address for feedback,in the article.
● We encourage authors to send a short profile of professional achievements and a recent photograph,preferably in colour,high resolution with a good contrast.
Email your contribution to: viveka.r@expressindia.com viveka.roy3@gmail.com Editor, Express Healthcare
Bridging the diagnostic divide: Transforming healthcare in tier 2 and 3 cities
Brijesh Suneja, Managing Director,Phantom Healthcare explains how PPPs are playing a critical role in transforming diagnostics in tier 2 and 3 cities
India’s tier 2 and tier 3 cities are undergoing a significant transformation in healthcare, particularly in the field of diagnostics. Historically, these regions have faced considerable challenges, including limited access to advanced diagnostic infrastructure, a shortage of trained professionals, and low awareness about the importance of preventive healthcare. However, recent developments are paving the way for improved access, though challenges persist.
Diagnostic facilities in tier 2 and 3 cities have traditionally relied on basic setups, often equipped with outdated technology. Advanced diagnostic tools such as MRI, CT, and PET-CT scanners remain scarce, leading to a reliance on urban centers for comprehensive diagnostic services. This not only delays critical care but also places a financial burden on patients traveling long distances. Additionally, high patient volumes in these limited facilities contribute to longer wait times, reducing the efficiency and effectiveness of healthcare delivery.
Technologyemerging as a game-changer
Technology is emerging as a game-changer in bridging geographical barriers. Telediagnostics, for example, allows healthcare providers to share imaging results and collaborate with specialists in urban centers, ensuring
Collaborative efforts between the government and private sector are creating opportunities for these professionals to grow their careers while addressing the healthcare needs of tier 2 and 3 cities
timely diagnosis for patients in remote locations. AI-powered tools are further enhancing diagnostic accuracy and speeding up the interpretation of imaging results.
Mobile diagnostic units are also making strides in extending the reach of diagnostic services. These units bring
imaging equipment directly to underserved areas, providing on-the-spot testing and reporting. Additionally, cloudbased data storage systems facilitate seamless communication between diagnostic centers in smaller towns and expert radiologists in metro cities, enabling faster decision-making and treatment
planning.
Role of Public-Private Partnerships (PPPs)
PPPs are playing a critical role in transforming diagnostics in tier 2 and 3 cities. Government initiatives like Ayushman Bharat are partnering with private healthcare providers to establish diagnostic centers in underserved areas. These collaborations leverage the expertise of private entities while utilising government support to expand access.
Refurbished radiology equipment has become an essential component of this growth, offering a cost-effective alternative to new machines. By integrating refurbished equipment into diagnostic facilities, healthcare providers can deliver high-quality services without the financial strain of acquiring new systems.
Building a skilled workforce
A robust diagnostics infrastructure requires a skilled workforce, and training programs are addressing this need. Dedicated centers are being established to train lab technicians, radiology technologists, and biomedical engineers. Online certification programs and tele-education platforms are further empowering professionals in remote locations, ensuring they are equipped to operate advanced equipment and provide highquality care.
Incentives to retain skilled professionals in smaller cities
are also crucial. Collaborative efforts between the government and private sector are creating opportunities for these professionals to grow their careers while addressing the healthcare needs of tier 2 and 3 cities.
Wayforward
While progress is evident, challenges remain. High costs of diagnostic equipment, difficulty in retaining skilled professionals, and low awareness about p revent ive diagnostics continue to hinder growth. However, opportunities abound. The increasing affordability of refurbished equipment, growing awareness of healthcare needs, and the potential of technology to address access gaps are paving the way for a brighter future.
To truly transform diagnostics in tier 2 and 3 cities, the focus must be on scaling infrastructure, promoting public-private collaborations, and investing in education and awareness campaigns. Sustainable solutions, such as leveraging refurbished radiology equipment, can help expand diagnostic capabilities rapidly without overburdening healthcare budgets.
In conclusion, the journey to transform diagnostics in India’s tier 2 and 3 cities is both challenging and promising. By embracing innovation, fostering collaboration, and investing in people and technology, we can ensure that quality healthcare reaches every corner of the nation.
Technological innovation revolutionising healthcare deliveryin tier 2 and 3 cities
Vijay Kumar, Chief Commercial Officer,Transasia Bio-Medicals Ltd.stresses that most
fundamental to accessibility is technological leap in diagnostics instruments which are now making a range of high-quality tests possible even in smallest of labs
India's healthcare sector is witnessing a transformative phase, characterised by increased accessibility and improved outcomes. While significant progress has been made, tier 2 and tier 3 cities continue to face critical challenges in diagnostics. These include limited infrastructure, long TAT, affordability barriers, and a shortage of skilled professionals. Addressing these gaps is vital for building a resilient, future-ready healthcare ecosystem that delivers quality care to every citizen.
In recent years, India has made significant strides toward creating a more inclusive and citizen-focused healthcare delivery system. This commitment to improving health outcomes and quality of life has become a cornerstone of the nation's growth story. Key factors driving this transformation include digital innovation, enhanced hospital efficiency, greater appeal of Indian healthcare as a medical tourism destination, increased health insurance penetration, and strategic expansion into tier 2 and tier 3 cities, as well as rural areas. Further, the demand for diagnostic testing is rising rapidly from smaller towns pushing the organised diagnostic services players to focus on penetrating deeper into these markets. Currently, smaller towns contribute approximately 40 per cent of the overall revenues in the diagnostics industry, highlighting the growing demand for quality healthcare services beyond urban centers. However, to unlock the full potential of these markets, systemic challenges must be addressed.
Driving innovation through technology
Technological innovation is revolutionising healthcare delivery in tier 2 and tier 3 cities. Most fundamental to accessibility is technological leap in diagnostics instruments which are now making a range of high-quality tests possible even in smallest of labs. The integration of artificial intelligence (AI) and machine learning in diagnostic tools is enabling faster and more accurate disease detection, even in resource-limited settings.
Remote interpretation of diagnostic results, mobile health units, and point-of-care devices are breaking down geographical barriers, making diagnostics more accessible and cost-effective. Tele-diagnostics and digital health solutions are also transforming how healthcare services are delivered in smaller towns. These technologies allow specialists in metro cities to remotely interpret test results, thereby improving diagnostic accuracy and reducing turnaround times.
Transasia Bio-Medicals has consistently prioritised innovation with affordability and scalability in mind. The company’s fully automated biochemistry analysers, which have achieved BIS certification, are a testament to its commitment to providing high-quality, cost-effective diagnostic solutions. The company puts significant focus on R&D to develop extremely reliable assays which are suitable for Indian needs. Such advancements play a crucial role in ensuring that patients in tier 2 and 3 cities receive timely and accurate diagnoses. As an example, In India, the prevalence of abnormal hemo-
globin S (sickle cell trait) is particularly high among tribal populations in the central, southern, and western states, with some communities showing a prevalence as high as 48 per cent of the population. For such situations, Transasia has developed in-vitro immunochromatographic assay, that can differentiate between normal hemoglobin A (HbA) and abnormal hemoglobin S (HbS) in a whole blood sample, and is made in the country.
Public-Private Partnerships (PPPs):
Enhancing accessibility PPPs are emerging as a key strategy for bridging the diagnostic gap in underserved regions. These partnerships leverage the expertise, technology, and investments of the private sector, combined with the infrastructure and outreach capabilities of the public sector.
Successful examples of PPP initiatives include diagnostic labs in district hospitals, subsidised screening programs, and mobile diagnostic units. Such collaborations have demonstrated the potential to expand access to quality diagnostics, particularly in remote and resource-constrained areas.
Transasia Bio-Medicals has been at the forefront of this movement, working to establish a strong presence across thousands of pin codes. By pooling resources and fostering collaboration, PPPs ensure that diagnostics become more affordable and accessible, benefiting millions of patients in smaller towns.
Addressing the workforce challenge
One of the most pressing challenges in tier 2 and 3 cities is the lack of trained laboratory technicians and healthcare professionals. This skills gap not only affects the quality of diagnostic services but also limits the sector's ability to scale effectively.
Comprehensive training programs are essential to bridge this divide. Transasia’s Erba Institute of Medical Lab Technology in Panchgani (Maharashtra) has taken proactive steps by launching initiatives focused on upskilling lab technicians, providing hands-on training, and introducing standardised diagnostic protocols. Collaborations with educational institutions and healthcare organisations can further strengthen these efforts, ensuring a steady pipeline of skilled professionals to meet the growing demand.
Understanding the skill challenges, Transasia continuously innovates to make its lab solutions easier to run, by minimising the number of consumables required to run the instruments.
Opportunities and growth potential
Despite these hurdles, the opportunities for growth are substantial. Digital health solutions,
AI-driven diagnostic tools, and telemedicine platforms are poised to transform healthcare delivery in these regions. Government initiatives like Ayushman Bharat provide a robust framework for expanding healthcare access and affordability. Additionally, the rising demand for quality healthcare services in smaller towns presents a compelling case for increased private sector investment. Transasia operates with the vision and unwavering commitment towards the “Make in India – make for the world”.
The road ahead
The diagnostics sector in tier 2 and 3 cities is at a pivotal juncture. By addressing existing challenges and leveraging emerging opportunities, India can transform its healthcare landscape to meet the needs of every citizen. At Transasia, we are committed to driving this change through innovative, costeffective diagnostic solutions and meaningful collaborations. Our vision is to create a healthcare ecosystem that prioritises accessibility, affordability, and quality. By working together with stakeholders across the public and private sectors, we can ensure that every Indian, regardless of location, has access to the diagnostics they need. As healthcare demand continues to grow in smaller towns, the focus must remain on building resilient, future-ready systems that cater to the unique needs of these communities. With the right investments, policies, and partnerships, the dream of a healthier India can become a reality.
POST EVENTS
AOCR 2025 successfullyconcludes in Chennai
The 77th Annual Conference of the Indian Radiological and Imaging Association (IRIA) and the 23rd Asian Oceanian Congress of Radiology (AOCR 2025) took place from January 23-26, 2025, at the Chennai Trade Center, Chennai. This landmark event symbolised the strong partnership between the Asian Oceanian Society of Radiology (AOSR) and IRIA, with a shared vision of advancing radiology and patient care across the region.
Under the theme "Clinical Radiology Decoded - See like a Surgeon: Think like a Physician," AOCR 2025 emphasised the critical role of radiologists in bridging clinical precision with holistic medical care.
The event was not only the largest radiology conference in Asia but also the third biggest worldwide, attracting over 5000+ delegates.
The event also saw participation from renowned global experts, industry leaders, and exhibitors showcasing groundbreaking advancements in radiology technology.
Along with scientific paper presentations highlighting cutting-edge research, more than 350 world-class faculties delivered insightful lectures across all radiology subspecialties. Prestigious institutions such as RSNA, ECR, KCR, and AOSR countries hosted intersociety and interspecialty symposiums and experts and decisionmakers discussed future trends in radiology and healthcare.
Poster presentations attracted widespread participation, providing a platform for young radiologists and researchers to display their innovative work.
The event featured an extensive exhibition arena where top industry players showcased the latest innovations in radiology technology. Leading exhibitors included
Sanrad, Medikabazaar, Phantom Healthcare, Siemens, BPL Medical Technology, Fujifilm, and GE Healthcare, among others.
Ratish Nair, CEO, Sanrad, shared his thoughts on the event's success, stating, "One of the most successful medical imaging events organized by the IRIA Chennai team. We had a footfall of more than 4,500 delegates at our booth. Sanrad sponsored the complete academic events, including the international quiz, paper, and poster presentations, distributing over 250 prizes. Additionally, we launched our state-of-the-art digital PETCT, designed and developed by FMI USA, and showcased the latest Fujifilm CT/MRI."
AOCR 2025 and IRIA's 77th Annual Conference set a new benchmark for radiology conferences in India and beyond. With its robust scientific program, high-profile international collaborations, and cutting-edge industry exhibits, the event successfully advanced the discourse in medical imaging and radiology. The conference's overwhelming success further cements India's role as a global hub for radiological innovation and education.
India triumphs in international radiologyquiz at AOCR 2025
Team of Indian radiologists beat doctors from 20 countries to bag the first prize at the first International radiology quiz conducted in Chennai as a part of the Asian Oceanic Conference of Radiology (AOCR).
Dr Dhanalakshmi V and Dr Roopini K, representing India are post graduate residents from Stanley Medical College and Hospital, Chennai. They won this battle of brains against international representatives from Chinese Taipei, Hong King, India, Indonesia, Italy, Japan, Kazakhstan, Kenya, Malaysia, Morocco, Nepal, Oman, Qatar, Serbia, Spain, Sri Lanka, Thailand, Turkey, United Kingdom, Uzbekistan.
The second and third prizes were bagged by Thailand and the United Kingdom respectively.
Dr Balaji P, Dean of Stanley Medical College and Dr Amarnath C, head of the department of Radiodiagnosis congratulated and felicitated the winners. The winners received a cash prize of two lakhs for the quiz, and another two lakhs was awarded by the Indian Radiological and Imaging As-
sociation (IRIA) for their victory.
Sanrad proudly sponsored the prizes for academic events at AOCR 2025, reinforcing its commitment to promoting excellence in radiology. All semifinalists of the prestigious international quiz, including 42 international delegates and 4 Indian delegates, were hon-
ored with gold mementos.
Winners of the paper presentation competition, spanning seven categories, received Amazon vouchers worth Rs 10,000, Rs 7,000, and Rs 5,000 for first, second, and third place, respectively.
Similarly, winners of the poster presentation, across 26 categories, were awarded
Amazon vouchers of Rs 6,000, Rs 4,000, and Rs 2,000. Additionally, the winners of the “Case of the Day” competition received Amazon vouchers as well.
Through these awards, Sanrad aims to recognise and encourage young talent, fostering academic excellence in the field of radiology.
POST EVENTS
BPLMedical Technologies shines at AOCR 2025
BPL Medical Technologies Pvt. Ltd., one of India's most trusted and reputed medical device companies, reaffirmed their commitment to excellence at the Asian Oceanian Congress of Radiology (AOCR) 2025, held in Chennai from January 23rd to 26th, 2025. As a Gold Sponsor of the event, the company made a lasting impression on several healthcare professionals, industry experts as well as radiology enthusiasts alike with their advanced medical solutions.
Unveiling the future of radiologyand imaging
At AOCR 2025, BPL Medical Technologies took centre stage by unveiling its latest advancements in radiology and imaging technology. One of the key moments was the much-awaited introduction of their two ultrasound solutions under the BPL Alpinion series, namely XCUBE 60 and XCUBE i8. These systems are crafted to seamlessly integrate into existing healthcare workflows and deliver superior imaging experience with enhanced efficiency, advanced transducer technology, high image quality, and user-friendly interfaces. These features make them ideal tools for radiologists aiming to deliver accurate and timely diagnoses.
Adding to the excitement, the company also introduced Artificial Intelligence (AI) to its Digital Radiography solution - in the BPL Fixed and Mobile DR. This AI integration offers some unique AIpowered modules such as Image Quality Check, Incidental Findings, Musculoskeletal Findings, Image Triaging, and so much more, thereby empowering radiologists with precision, speed and greatly improving their capabilities in patient diagnoses.
Ahub of engagement & collaboration
BPL MedTech's booth at
AOCR 2025 turned into a hub of discussion, drawing in a large number of audience and radiology experts at the event. Several renowned professionals visited their booth eagerly, some of which include Dr Harsh Mahajan (Founder and Chief Radiologist -Mahajan Imaging &
Labs), Dr Piyush Joshi (Head Of Radiology - Inlaks & Budhrani Hospital Pune, Maharashtra), Dr Aarthi Govindarajan (Executive Director & Chief Radiologist - Aarthi Scans & Lab, Chennai), Dr Ashok Khurana (Chairman & Consultant in Reproductive Ultrasound - The Ultrasound
Lab, New Delhi) and Dr. P.M. Venkata Sai (Professor and Consultant RadiologistChennai).
Post the showcase of their latest products, visitors were treated with discussions & product demonstrations, followed by hands-on workshop using the XCUBE 60 and XCUBE i8 ultrasound machines. The ultrasound machines captivated the attendees with its seamless functionality and exceptional features, while the introduction of AI in Digital Radiography sparked discussions between the visitors and the BPL team on product capabilities, challenges in the evolving field of radiology, and conversations on the future of diagnostic imaging. Several radiologists and experts lauded BPL's forward-thinking approach and dedication
to addressing the challenges in radiology.
Praise from the radiologycommunity
In addition, during a live workshop focused on the XCUBE90 for Wrist & Hand (MSK) and Orbital Ultrasound, Dr Ashwani Launde and Dr Venkata Sai highly praised the performance and capabilities of the machine. They highlighted its advanced imaging quality, user-friendly interface, and precision in diagnosing musculoskeletal and orbital conditions. The workshop provided an excellent platform for the audience to gain hands-on training with the XCUBE90, allowing them to experience its cutting-edge features firsthand. This interactive session not only enhanced their understanding of the machine but also demonstrated its clinical effectiveness in real-time scenarios. Avision for the future BPL Medical Technologies' participation at AOCR 2025 not only showcased its latest innovat ions but also reinforced its position as a leader in the medical device industry. By combining cuttingedge technology with a deep understanding of the needs of healthcare professionals, BPL MedTech continues to pave the way for a brighter future in radiology and diagnostic imaging.
About BPLMedical Technologies
Founded in 2013, BPL Medical Technologies is an Indian medical device company dedicated to developing highquality tech solutions for the healthcare industry. With a focus on diagnostics and imaging, BPL MedTech strives to empower healthcare professionals with tools that enhance patient care and operational efficiency.
For more information about BPL Medical Technologies and their offerings, visit www.bplmedicaltechnologies.c om or contact them
LEADERSHIP
Shaping leadership for dynamic Indian healthcare landscape
In recent years,Amrop India has led leadership searches for newly created roles designed to address strategic shifts and the industry's readiness for new operating models. Preety Kumar, Managing Partner,and Tarunesh Madan,Co-Managing Partner at Amrop India,discuss key developments in healthcare leadership talent
The healthcare services industry in India continues to be highly dynamic, necessitating edge leadership capabilities to scale up the business with patient-centricity and technology at the centre. Digital continues to disrupt in a significant way also presenting opportunities for businesses to create non-linear business models while leveraging the core.
In the last few years, Amrop India has conducted leadership searches where new leadership roles have been created in the industry to respond to these strategic shifts as well as market readiness to absorb new operating models. 2025 will be a continuation of this where the following trends related to leadership talent in healthcare will continue to shape the agenda.
Digital health leadership pivoting to digital business leadership
Digital health technologies have already become more mainstream and healthcare organisations are responding by bringing in digital beyond the conventional Chief Digital Officer (CDO) or CIO role. Forward-looking organisations are already increasingly looking for CEOs and business leaders with depth and expertise in digital models and a strong ability to bring technology to the core of healthcare services.
While these business leaders will continue to drive the commercial business performance, the primary ask is
to pivot to digital forward models that enhance patient care, accessibility (alternate operating models with technology taking the lead to reach the patients), and unlocking efficiencies in healthcare service delivery operations.
The role of Chief Technology Officer has been a prime mover in a health-tech business or health start-ups. However, even core Healthcare organisations in India have now been formally align-
ing digital business responsibilities to the CEOs or have an upgraded Chief Digital Officer role.
Continued rise of physician-executives
There has been a growing
trend of healthcare organisations seeking Business Leaders who have clinical experience in addition to business acumen. This trend, which has been much mor e p revalent in mature markets globally, has seen high relevance
PreetyKumar
Tarunesh Madan
in the Indian context over the last few years, and 2025 will be no different.
The physician-business leaders are able to integrate seamlessly into complex healthcare service organisations, bringing immediate credibility with the doctors and healthcare professionals. They also bring valuable clinical insights to optimise healthcare systems, manage clinical practices, improve patient care delivery models, and bridging the gap between healthcare professionals and business and operations leaders.
Business operations leadership with multidisciplinarycontext
The complexity of modern healthcare services has led to a demand for multidisciplinary leadership especially when it comes to running core business operations efficiently and with agility. Leaders with expertise across 24 X 7 service operations, operational P&L, patient experience, marketing, revenue growth, process design, and efficiencies, and large team leadership continue to be in demand for roles such as Hospital CEOs, Chief Operations Officers (COOs), and Regional CEOs.
Growing demand for healthcare innovators
The role of Chief Innovation Officer is also increasingly taking centre stage in the In-
Forward-looking organisations are already increasingly looking for CEOs and business leaders with depth and expertise in digital models and a strong ability to bring technology to the core of healthcare services
dian healthcare services industry as the sector continues to evolve at the back of technology disruption, changing patient needs, and the rise of digital health. A “Chief Innovation Officer” role is being architected to drive innovation across the organisation, embrace technologies for world-class care delivery, and creating new healthcare solutions and business models.
As per Amrop India’s observations, while the role is still emerging, most healthcare organisations in India are anchoring certain responsibilities with their key leaders to now also focus on unlocking inn ovation. An integrated role will cut across digital health transformation, data and analytics, ecosystem development through partnerships, and creating models to deliver cost efficiencies.
Most organisations continue to appoint senior executives with primary mandates on technology integration, AI-powered diagnostics, digital platforms to enhance patient care, digital
tools to optimise healthcare delivery, low-cost healthcare solutions, digitisation of medical records, leveraging AI, and robotics in clinical procedures.
Patient-centric leadership roles
As commercial business competition increases and patient expectations evolve, healthcare organisations in India are placing greater emphasis on patient-centric care models. Leaders with strong expertise in patient experience, engagement, and innovative care models will be in high demand.
While roles in the domains of operational and service excellence have always been there with leading industry players, the industry is also upgrading the context as “Chief Patient Experience Officers” integrating Patient care, innovation, and engagement.
Historically many of the leaders have come from a customer experience, service excellence, and business excel-
lence background with exposure to large-scale consumer services models like hospitality, telecom, etc. However, with the changing context, edgier leaders are being bought into these roles. These leaders have expertise in evolved healthcare delivery models built with improving patient outcomes as core and are able to integrate technology, process, and experience design. Their backgrounds are also a lot more dynamic and well-rounded.
International context of healthcare services from India
India continues to emerge as a global healthcare hub, particularly in medical tourism, and as a result, healthcare providers are creating focused roles as well as looking for business leaders who understand global healthcare dynamics, international partnerships, and cross-border healthcare delivery.
These leaders will drive strategies for expanding healthcare services interna-
tionally, working with global partners, bring in world-class practices on building clinical centres of excellence, and world-class practice while adapting to global healthcare standards. We are also seeing interesting India-Out global business models being built in adjacent spaces.
Leadership in the Indian healthcare services industry is transforming to meet the needs of a rapidly evolving healthcare landscape. The demand for digital-savvy, multidisciplinary, inn ovative leaders with a global perspective continues to be high; as well as those who can drive patient-centric models and outcomes. Healthcare providers in India are also conducting global executive searches to create access to these leaders to drive innovation. At the same time, given the Indian market’s competitive nature, expected speed of execution, and unique cultural context; these leaders need to demonstrate high ability to adapt, carry larger teams along, and lead through influencing and building high credibility, will be key for success. This is where erstwhile physicians who have pivoted to business and commercial leadership roles successfully bring the right intersection. Amrop India's Healthcare Practice contributes by helping organisations identify and develop leaders suited to the unique demands of India’s healthcare industry.
MEDTECH
Unleashing India's medtech potential: Paving the path to a Viksit Bharat
Himanshu Baid, Managing Director,Poly Medicure
emphasises that one of the key drivers of India’s medtech transformation is innovation
As India embarks on its journey towards a “Viksit Bharat” by 2047, the medical technology (medtech) sector plays a pivotal role in transforming the nation’s healthcare landscape. With an ambitious vision to emerge as a global leader in medical technology, India is steadily paving the way through innovation, regulatory reforms, and a shift towards high-value medical devices. The government’s focus on fostering R&D, along with a thriving startup ecosystem, is driving the growth of the medtech sector, positioning India to address both domestic healthcare needs and global demands.
One of the key drivers of India’s medtech transformation is innovation. The country’s vibrant startup ecosystem, coupled with an increasing number of health-tech ventures, is spearheading groundbreaking solutions in diagnostics, medical devices, and healthcare delivery. Indian medtech startups are utilising cuttingedge technologies like artificial intelligence, robotics, and the Internet of Things (IoT) to develop medical devices that enhance patient care, improve outcomes, and reduce healthcare costs. These startups are not only addressing local healthcare challenges but are also developing products designed to meet global standards, making India a major player in the global medtech market.
India has been actively working to create a favourable regulatory environment for the medtech industry. The government has implemented several initiatives to streamline the approval process for medical devices, making it easier for companies to intro-
duce innovative products into the market. In 2020, the Medical Device Rules were amended to regulate medical devices under the Drugs and Cosmetics Act, ensuring greater standardisation and safety. These changes, along with the establishment of dedicated medical device parks and hubs, are accelerating the growth of the sector.
A robust and resilient supply chain is essential for the growth of the medtech sector. India’s supply chain for medical devices is undergoing a transformation with an emphasis on localisation. The country is moving away from its dependence on imported medical devices and focusing on building indigenous manufacturing capabilities. The
production of critical components such as electronics, microchips, medical-grade steel, and specialised plastics is now a priority. This shift, supported by government, aims to reduce the reliance on imports and strengthen the domestic manufacturing base. India is gradually shifting its focus from manufacturing low-cost consumables to high-
value, mid and high-technology medical devices. This transition is vital for establishing the country as a global medtech powerhouse. Companies are investing in advanced technologies to produce complex devices like surgical instruments, diagnostic equipment, and implantable devices that meet international standards.
India’s healthcare focus is evolving from a reactive to a preventive approach. There is now a strong emphasis on preventive healthcare, wellness, and early intervention. Medical technologies that enable remote monitoring, telemedicine, and personalised healthcare are playing a crucial role in this shift. By enabling early diagnosis and timely intervention, these innovations are reducing the burden on the healthcare system and improving the overall quality of life.
Government’s commitment to boosting R&D in the medtech sector is evident through its policy initiatives and financial support. The introduction of tax incentives, grants, and funding is helping to fuel innovation and foster a culture of collaboration between academia, industry, and startups. Additionally, the government is making efforts to promote export opportunities, positioning India as a global supplier of high-quality, costeffective medical devices.
India’s path to a “Viksit Bharat” by 2047 in the medtech sector is an exciting journey driven by innovation, regulatory reforms, and a shift towards high-value manufacturing. As India continues to evolve, the medtech sector will play a crucial role in shaping the nation’s healthcare future and establishing India as a global medtech capital.
RADIOLOGY
Advancing cancer care with precision: The EDGE radiosurgerysystem
Malti Sachdev, Sr Vice President and Head,Varian - ASiemens Healthineers Company highlights that aided with high-precision beam shaping,EDGE by Varian focuses radiation doses precisely on the tumor while minimising damage to surrounding healthy tissues
Cancer treatment has seen noteworthy advancements in recent years, with innovations in radiation therapy and radiosurgery significantly improving patient outcomes. Radiation therapy, a critical tool in oncology, targets and eradicates cancer cells using high-energy radiation. Traditionally, this involves delivering lower doses of radiation over multiple sessions to treat larger areas. In contrast, radiosurgery offers a more focused approach, delivering high doses of radiation in fewer sessions to target smaller or inoperable tumors with great precision.
Among the most innovative solutions in this field is Varian's EDGE, a cutting-edge radiosurgery system that exemplifies the future of cancer care. EDGE is designed to deliver highly accurate radiation therapy, employing real-time tumor tracking technology to monitor the tumor’s movement throughout the treatment. This ensures that radiation is delivered precisely, even if the tumor shifts due to patient movement or physiological changes. This capability is vital for treating tumors that may be in constant motion or located in challenging areas.
The EDGE system features image-guided radiation therapy (IGRT) capabilities. Before and during treatment, EDGE uses advanced imaging technology to accurately locate and target the tumor. Aided with high-precision beam shaping, EDGE focuses radiation doses precisely on the tumor while minimising damage to surrounding healthy tissues. It is particularly effective for tumors in complex areas like the brain and spine, where traditional surgical approaches
might be risky or impractical.
EDGE offers rapid treatment delivery, significantly reducing the overall time required for therapy while enhancing patient comfort. Unlike conventional radiation therapy, which typically involves multiple sessions spread over weeks or months, EDGE delivers a high dose of radiation in fewer sessions. This streamlined approach not only makes the treatment process more convenient for patients but also minimises disruptions to their daily lives. By cutting down on
the number of visits and treatment time, EDGE allows patients to return to their routines sooner, facilitating a quicker recovery and offering greater flexibility in scheduling.
The integration of HyperArc technology with EDGE further enhances its capabilities. HyperArc’s automated radiosurgery solutions streamline the treatment process with specialised algorithms for automatic planning and delivery. This optimisation allows for simultaneous treatment of multiple tumors from a single
point, known as a ‘single isocentre,’ with minimal manual adjustments. Consequently, patients benefit from a precise, faster, and more comfortable treatment experience.
EDGE is versatile, and suitable for treating various cancer types. Its ability to address both primary and metastatic tumors with high precision makes it a valuable tool in modern oncology.
The system's non-invasive nature means no incisions, no lengthy recovery periods, and minimal risk of complications
such as infections. This is particularly beneficial for patients who may not be suitable for surgery due to age or other health conditions.
In India, where the population is vast and cancer cases are on the rise, the introduction of EDGE is particularly beneficial. EDGE provides a significant advantage by offering precise, high-quality care locally, thus alleviating the need for patients to travel abroad for state-of-the-art treatment. This technology enhances the capacity of Indian healthcare facilities to deliver world-class care, contributing to better outcomes and accessibility for patients in the country.
Varian's EDGE signifies a transformative shift in radiosurgery, combining precision, efficiency, and versatility to elevate comprehensive cancer care. As oncology continues to advance, technologies like EDGE will play a crucial role in shaping future treatments, offering patients innovative solutions that enhance both effectiveness and quality of life.
HOSPITAL INFRASTRUCTURE
Flexible and future-proof hospital design: Planning for uncertainty
Bakul Chandra, Founding Partner and Mentor at Renascent Consultants,emphasises that while scalability enables hospitals to expand as needed,versatility ensures that their spaces remain dynamic and resource-efficient
The healthcare sector has faced immeasurable challenges and undergone several changes in the last few years. Designing hospitals that are flexible and future-proof is most crucial in today's rapidly changing healthcare landscape. This may involve moving away from traditional building design ideas and embracing adaptable design frameworks that can cater to evolving needs.
These include design optimisation and utilising smart cutting-edge technologies that can enhance patient care, streamline operations, and support future upgrades.
Scalabilityand versatility in design
A scalable hospital design enables healthcare providers to respond to changing demands, expand services, and incorporate new technologies while minimising disruptions to patient care. Hospitals must be equipped to grow and adapt as circumstances demand. Spatial design needs to offer a forward-thinking solution, enabling facilities to expand or contract with minimal disruption. Spaces designed
with modularity in mind allow for seamless transitions.
While scalability ensures hospitals can expand as needed, versatility ensures that the spaces within remain dynamic and resource-efficient.
In contemporary hospital design, every square metre must serve a purpose, or ideally, multiple purposes. Flexible layouts with open plans and movable partitions empower hospitals to reconfigure spaces based on immediate needs. For instance, diagnostic areas can transform into outpatient clinics or even temporary isolation units, maximising the use of available resources.
in times of high activity, the hospital remains intuitive and efficient to navigate.
Sustainabilityas a foundation for resilience
Future-proof hospital design must be rooted in sustainability. By integrating energy-efficient systems, renewable energy sources, and eco-conscious materials, architects can reduce a hospital’s environmental footprint while improving its resilience to external disruptions.
Natural ventilation, daylight-
Incorporating healing spaces,such as green courtyards or terraces,further enhances the versatility of hospital design.These areas provide moments of respite for patients and staff, promoting recovery and reducing stress
hance operational efficiency but also provide a buffer against climate-related challenges. Sustainability is not just about environmental responsibility; it’s a practical strategy for ensuring long-term cost-effectiveness and reliability.
The role of architects in healthcare design extends beyond creating functional spaces; it is about crafting environments that inspire confidence and resilience. Scalable, versatile, and sustainable design principles form the backbone of future-ready hospitals, enabling them to adapt to the ever-changing landscape of healthcare. While collaboration among architects, healthcare providers, and policymakers is crucial to realise these visions, it is the thoughtful integration of simple design strategies that could transform the hospitals of tomorrow.
Incorporating healing spaces, such as green courtyards or terraces, further en-
hances the versatility of hospital design. These areas provide moments of respite for patients and staff, promoting recovery and reducing stress. Thoughtful spatial planning also improves wayfinding, ensuring that even
ing, and the use of durable, lowimpact materials like recycled steel or low-carbon concrete contribute to healthier and more sustainable environments. Green roofs and rainwater harvesting systems not only en-
“Cultural nuances are whispers, but functionality is the roar for a developing nation. We must craft typologies that address the healthcare needs of the masses first and foremost. A healthy populace is, after all, the foundation of a thriving society”
HEALTHCARE TRACKER
Ajourneyof flowcytometry: Single cell analysis to rare clone detection
Dr
Pradeep Kumar Rai, Manager Application,Sysmex
India Pvt Ltd explains how low cytometry is still leading technology for single cell analysis
Despite many decades of research for developing technologies for unmasking properties of single cell to differentiate one clone to another, flow cytometry is still leading technology for single cell analysis which relies on fundamental of qualitative and quantitative estimation of nucleic acids, surface and intracellular antigens by fluorescent dyes or fluorochrome tagged antibodies. The first keystone for development of flow cytometer was founded in 1904 by Kohler by utilising fluorescent microscopy for analysis of epidermal cells followed by development of microfluorometric scanner in 1951 by Robert Mellors for actual quantification of cell. The first fluorescencebased flow cytometry device (ICP 11) was developed in 1968 by Wolfgang Göhde from the University of Münster which pave the way for development of currently available advanced flow cytometers.
Multicolor flow cytometry experiments are being performed nowadays and are impossible without state-of-art fluorescent dyes with the feature of brighter, less spillover
and spread with other dyes. A journey of fluorescent dyes started in early 1970 with development of organic dyes like fluorescein and rhodamine followed by phycobilin proteins, tandem dyes, quantum dots and now super bright polymer dyes have enabled identification of multiple dim density antigens simultaneously.
Concurrent with an exponential increase in the availability of fluorochromes urged for advancement in the flow cytometer equipped with range of lasers and advanced detector technology like photomultiplier with large detection area and higher amplification gain of up to 108 for efficient multicolor immunophenotyping.
In the path of development, where conventional flow cytometer collects narrow band of the emission spectrum by using compensation, can detect 28+ colors, spectral flow cytometers collect the full spectrum by autofluorescence extraction and unmixing of
Furthermore, A hybrid technology of flow cytometry and mass spectrometry is developed where antigens are targeted by metal tagged antibodies and quantified with time-of-flight by mass spectrometry. This enables measurement of up to 50 simultane-
Ahybrid technology of flow cytometry and mass spectrometry is developed where antigens are targeted by metal tagged antibodies and quantified with time-of-flight by mass spectrometry
spectral overlap technology and can detect 40+ colors. The introduction of spectral flow cytometry has revolutionized this technique to identify new cellular subsets by simultaneous detection of multiple parameters which paved the way for exploring new subsets for better understanding of disease state.
ous parameters without challenge of autofluorescence and spillover.
Flow cytometry is still a progressive technology where improvements are needed to further improve sensitivity, speed, sample loss and electronics for better data resolution and faster turnaround time.
Revitalise pelvic health with silicone kegel balls
Vishal Nair, Senior Executive-Global Healthcare Device,Ami Polymer Pvt Ltd highlights the benefits,usage,and considerations for incorporating silicone Kegel balls into wellness routine
Pelvic floor health is an often-overlooked aspect of overall wellness, yet it plays a crucial role in various bodily functions and quality of life. Whether you're seeking to improve bladder control, enhance sexual health, or aid postpartum recovery, silicone Kegel balls offer an effective and user-friendly solution.
Understanding Silicone Kegel balls
Nowadays the need for biocompatibility is the key factor responsible for fueling the demand of medical grade silicones in the manufacturing of implants. In addition, rising health concerns coupled with the implementation of new technologies in the medical sector intensified the utilisation of medical-grade silicone, as it is highly biocompatible.
Silicone Kegel balls are small, weighted devices designed to be inserted into the vagina to help strengthen the pelvic floor muscles. These balls are crafted from medicalgrade silicone, a material known for its safety, flexibility, and ease of cleaning. The primary purpose of Kegel balls is to provide resistance during Kegel exercises, which are movements that involve contracting and relaxing the pelvic floor muscles.
Ami Polymer, a trustworthy partner for all silicone product consumer and new product developers has introduced its own pelvic health solution by virtue of more than two decades of expertise in silicone.
Benefits of using Silicone Kegel balls
1. Enhanced pelvic floor strength
Regular use of Kegel balls can significantly improve the strength and tone of the pelvic floor muscles. This is beneficial for preventing and managing conditions such as urinary incontinence, pelvic organ prolapse, and fecal incontinence.
Strong pelvic muscles support the bladder, uterus, and rectum, ensuring they function correctly.
2. Improved sexual health
Strengthening your pelvic floor can lead to increased sensitivity and stronger orgasms. Many users report enhanced sexual pleasure and satisfaction after incorporating Kegel exercises with silicone balls into their routine. These exercises can also help alleviate discomfort during intercourse caused by weakened pelvic muscles.
3. Postpartum recovery
After childbirth, many women experience weakened pelvic floor muscles, leading to issues like urinary incontinence and decreased vaginal tone. Kegel exercises with silicone balls can aid in postpartum recovery by restoring muscle strength and tone, helping new mothers regain control and confidence in their bodies.
4. Menopause management
During menopause, the decrease in estrogen levels can lead to a weakening of the pelvic floor muscles, resulting in symptoms such as vaginal dryness, discomfort, and urinary issues. Regular use of Kegel balls can help manage these symptoms by improving muscle tone and increasing blood flow to the pelvic region.
Howto use Silicone Kegel balls
Using silicone Kegel balls is straightforward, but it's essential to follow proper guidelines to ensure safety and effectiveness:
1. Choosing the right balls
Beginners should start with lighter and larger Kegel balls, which are easier to hold in place. As your pelvic floor strength improves, you can gradually progress to smaller and heavier balls for a more challenging workout.
2. Inserting the balls
Wash your hands and the Kegel balls with mild soap and
water before use. Apply a water-based lubricant to the balls for easier insertion. While in a comfortable position, gently insert the balls into your vagina, one at a time. The balls should rest comfortably a few inches inside the vaginal canal.
3. Performing Kegel exercises
Once the balls are in place, you can begin your Kegel exercises. Contract your pelvic floor muscles as if you are trying to stop the flow of urine. Hold the contraction for a few seconds, then relax for an equal amount of time. Start with a few repetitions and gradually increase the number as your muscles get stronger.
4. Removing and cleaning the balls
After completing your exercises, gently remove the Kegel balls by relaxing your pelvic muscles and pulling on the retrieval cord if present. Clean the balls thoroughly with mild soap and water, and store them in a clean, dry place.
Tips for success
1. Consistency is key
To see noticeable results, consistency is crucial. Aim to perform your Kegel exercises with the balls at least three to four times a week. Over time, you'll build the strength and endurance needed for optimal pelvic health.
2. Listen to your body
While Kegel exercises are generally safe, it's essential to listen to your body and avoid overexertion. If you experience any discomfort or pain, stop using the balls and consult with a healthcare professional.
3. Gradual progression
Start with shorter sessions and gradually increase the duration and intensity of your exercises. This approach will help prevent muscle strain and ensure steady progress.
4. Incorporate into daily routine
Integrate your Kegel exercises into your daily routine. You can perform them while
HEALTHCARE TRACKER
watching TV, reading a book, or even during your commute. This makes it easier to stay consistent and make pelvic health a regular part of your wellness regimen.
Addressing common concerns
1. Are Silicone Kegel balls safe?
Yes, silicone Kegel balls are safe when used correctly. Medical-grade silicone is hypoallergenic, non-porous, and easy to clean, making it a safe choice for intimate products. Ensure you follow the manufacturer's instructions and maintain proper hygiene.
2. How soon will I see results?
Results can vary depending on factors such as the initial strength of your pelvic muscles and the frequency of your exer-
cises. Many users report noticeable improvements within a few weeks to a few months of regular use.
3. Can I use Kegel balls during pregnancy?
It's best to consult with your healthcare provider before using Kegel balls during pregnancy. While Kegel exercises are generally beneficial during pregnancy, individual circumstances may vary, and professional guidance is essential.
4. What If I have a pelvic floor disorder?
If you have a diagnosed pelvic floor disorder, such as pelvic organ prolapse or chronic pelvic pain, consult with a healthcare professional before using Kegel balls. They can provide personalized advice and ensure that Kegel exercises are safe and appropri-
ate for your condition.
WhyAmi Polymer Kegal ball?
Ami polymer has included the “Medical Product- Kegal Ball” into its portfolio with various range of size and smooth texture and obviously the design of its own which will bring drastic change in medical device market. Kegal ball made up of medical grade silicone for
avoiding any kind of bacterial growth and to follow all its healthcare safety compliance.
Ami polymer with its Two decades of silicone expertise has manufactured Kegal Ball in ISO Class 10000 Cleanroom for providing a best solution for the seekers who trust us with their health and safety on line.
Medical product portfolio: Women hygiene product (Imasafe® Menstrual cup, Kegal Ball, Vaginal Pessaries), PEG tubing, Baby feeding cup, Voice Prosthesis, Larry tube, Silicone Mock vessel, Silicone tire etc.
We are currently catering our products to following industry: Pharma, Biopharma, FMCG, Engineering and medical sector.
Compliances available on Ami Polymer’s products:
Conclusion
Silicone Kegel balls offer a simple yet effective way to enhance pelvic floor health, improve sexual well-being, and aid in postpartum recovery. By incorporating these exercises into your regular wellness routine, you can enjoy numerous benefits and achieve greater control over your pelvic health. Remember, consistency and proper technique are key to reaping the full rewards of Kegel exercises. Embrace this empowering tool and take proactive steps towards a healthier, more confident you Ami Polymer believes in “business with ethics” and “Customer Satisfaction”
REGD.WITH RNI NO.MAHENG/2007/22045,POSTAL REGD.NO.MCS/162/2025 – 27,PUBLISHED ON 8TH EVERY MONTH, POSTED ON 14TH,15TH,16TH EVERY MONTH,POSTED AT MUMBAI PATRIKA CHANNEL SORTING OFFICE,MUMBAI – 400001
